Newest therapeutic strategies impacting on rarest thoracic malignancies: The clinical case report of biphasic pleural mesothelioma
F. Pellicioli,
L. Sala,
F. Colonese,
E. Belloni,
M.I. Abbate,
S. Canova,
A. D'Agostino,
D.L. Cortinovis
Affiliations
F. Pellicioli
CS Medical Oncology, IRCCS San Gerardo Dei Tintori Foundation, Monza, Italy; Department of Medical-Surgical Specialties, University of Brescia, Radiological Sciences and Public Health, Brescia, Italy
L. Sala
CS Medical Oncology, IRCCS San Gerardo Dei Tintori Foundation, Monza, Italy
F. Colonese
CS Medical Oncology, IRCCS San Gerardo Dei Tintori Foundation, Monza, Italy
E. Belloni
CS Pathological Anatomy, IRCCS San Gerardo Dei Tintori Foundation, Monza, Italy
M.I. Abbate
CS Medical Oncology, IRCCS San Gerardo Dei Tintori Foundation, Monza, Italy
S. Canova
CS Medical Oncology, IRCCS San Gerardo Dei Tintori Foundation, Monza, Italy
A. D'Agostino
CS Medical Oncology, IRCCS San Gerardo Dei Tintori Foundation, Monza, Italy
D.L. Cortinovis
CS Medical Oncology, IRCCS San Gerardo Dei Tintori Foundation, Monza, Italy; Medicine and Surgery Department, University of Milano Bicocca, Milan, Italy; Corresponding author. CS Medical Oncology, IRCCS San Gerardo Dei Tintori Foundation, Monza, Italy.
A caucasian 62-year-old woman, diagnosed with biphasic pleural mesothelioma (PM) of II stage and BAP1 loss, was treated with therapies included in clinical trial and Early Access Programmes (EAP). During her clinical history, radiological images presented an unusual representation of the disease, with a pseudo progression discussed many times by several specialists. The patient's overall survival improved as a result of the multidisciplinary team and the availability of medicines outside of clinical practice.
